Bill > S2076

This bill, the Pioneering Antimicrobial Subscriptions To End Up surging Resistance Act of 2021 (PASTEUR Act of 2021), establishes a program to develop antimicrobial innovations targeting the most challenging pathogens and most threatening infections. The key provisions include: 1) Creating a Committee on Critical Need Antimicrobials to develop a list of infections for which new antimicrobial drug development is needed, and establish regulations on favored characteristics for critical need antimicrobial drugs. 2) Allowing the Secretary to enter into "transitional subscription contracts" with antimicrobial developers prior to the implementation of the full subscription contract program. 3) Authorizing the Secretary to designate certain antimicrobial drugs as "critical need antimicrobials" and enter into subscription contracts with their developers, with contract amounts based on the drugs' favored characteristics. 4) Requiring sponsors of critical need antimicrobials to meet certain criteria, such as ensuring commercial availability, tracking resistance data, and completing postmarketing studies. 5) Establishing a hospital grant program to support efforts to judiciously use antimicrobial drugs and participate in surveillance programs. 6) Appropriating $11 billion to the Secretary to carry out the provisions of the bill.

Health and Social Services

https://www.congress.gov/bill/117th-congress/senate-bill/2076/all-info